Keith A. Goldan - 01 Dec 2025 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Signature
/s/ Michael A. Metzger, Attorney-in-Fact
Issuer symbol
SNDX
Transactions as of
01 Dec 2025
Net transactions value
$0
Form type
4
Filing time
01 Dec 2025, 16:30:03 UTC
Previous filing
07 Aug 2025
Next filing
06 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Goldan Keith A. Chief Financial Officer 730 THIRD AVENUE, FLOOR 9, NEW YORK /s/ Michael A. Metzger, Attorney-in-Fact 01 Dec 2025 0001495411

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Gift $0 -1,224 -1.3% $0.000000 92,452 01 Dec 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.